MDLZ Q3 2025 Earnings — Income Statement Breakdown
For its Q3 2025 period (ending 2025-09-30), MDLZ reported revenue of $9.7B, gross profit of $2.6B (26.8% gross margin), operating income of $744M, and net income of $743M (7.6% net margin). The flow of revenue into costs and profit is visualized below.
What changed
MDLZ was profitable; no comparable cached period is available.
| Comparison | Revenue | Net income | Net margin |
|---|---|---|---|
| Year over year | Not available | Not available | Not available |
| Quarter over quarter | Not available | Not available | Not available |
Consensus estimate data is not available for this report.
MDLZ Q3 2025 Income Statement
| Line item | Amount (USD) | % of revenue |
|---|---|---|
| Revenue | $9.7B | 100% |
| Cost of Revenue | −$7.1B | 73.2% |
| Gross Profit | $2.6B | 26.8% |
| Research & Development | — | 0.0% |
| Selling, General & Administrative | −$1.8B | 18.4% |
| Other Operating Expenses | −$73M | 0.7% |
| Operating Income | $744M | 7.6% |
| Other Income, net | $136M | 1.4% |
| Income Tax Expense | −$137M | 1.4% |
| Net Income | $743M | 7.6% |
Source: original SEC filing (filed 2025-10-28). Accession 0001628280-25-046750. Data normalized by EarningsFyi.